Wendy F. Dicicco - Jan 1, 2024 Form 3 Insider Report for Akari Therapeutics Plc (AKTX)

Signature
/s/ Wendy DiCicco
Stock symbol
AKTX
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
3
Date filed
1/2/2024, 08:00 PM
Previous filing
Jun 22, 2023
Next filing
Jan 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AKTX Stock Option (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 5M $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. One-hundered percent (100%) of the stock option vests and becomes exercisable on July 17, 2024 (first anniversary of the date of grant), subject to continued service with the Issuer. Notwithstanding the foregoing, should the Issuer terminate the Reporting Person for any reason other than for cause prior to the full vesting date, the stock option will continue to vest through the first anniversary of the date of grant or be accelerated, at the Issuer's option.